![](/img/cover-not-exists.png)
MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
Kim, Yu Jin, Choi, Jong-Sun, Seo, Jinwon, Song, Ji-Young, Eun Lee, Seung, Kwon, Mi Jung, Kwon, Mi Jeong, Kundu, Juthika, Jung, Kyungsoo, Oh, Ensel, Shin, Young Kee, Choi, Yoon-LaVolume:
134
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.28566
Date:
May, 2014
File:
PDF, 4.73 MB
english, 2014